{"cord_uid": "otf9ruvj", "sourcedb": "PMC", "sourceid": "PMC5827994", "divid": "29", "text": "ARDS is a multifactorial disease with a heterogeneous pathogenesis and variable timing and clinical presentations . Therefore , one specific therapy is unlikely to improve outcomes . Rather than excluding single therapeutic options , identifying patients ' risk factors and the individual ARDS stage may be more important for successful outcomes . We report here in our retrospective analysis that intravenous IgM administration in the initial stages of severe ARDS did not improve overall outcomes or the severity of disease .", "project": "cdlai_CORD-19", "denotations": [{"id": "A-biobert_T1", "span": {"begin": 410, "end": 414}, "obj": "Gene"}, {"id": 2, "span": {"begin": 0, "end": 5}, "obj": "Disease"}, {"id": 3, "span": {"begin": 10, "end": 33}, "obj": "Disease"}, {"id": 4, "span": {"begin": 289, "end": 294}, "obj": "Disease"}, {"id": 5, "span": {"begin": 461, "end": 466}, "obj": "Disease"}], "relations": [{"id": 1, "subj": "A-biobert_T1", "obj": 5, "pred": "interactWith"}]}